Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , , |
| Tipo de documento: | Artigo |
| Idioma: | por |
| Título da fonte: | Research, Society and Development |
| Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/17179 |
Resumo: | Chronic Obstructive Pulmonary Disease (COPD) is considered a set of respiratory diseases such as chronic bronchitis and pulmonary emphysema that are mainly characterized by progressive inflammation and reduced airflow in the airways. It developed mainly from active or passive smoking, inhalation of toxic gases or particles. Its treatment consists of reducing symptoms, progression and improving the lives of its patients. However, this treatment is limited and has side effects with prolonged use, which triggers the need to search for new therapies. The use of medicinal plants in the treatment of lung diseases is growing every day and is proving to be a viable and effective option. Its use is possible due to the presence of secondary metabolites, which have pharmacological activities such as anti-inflammatory and antioxidant. The objective of this work was to carry out a literature review of medicinal plants and active compounds used as a form of treatment for COPD from January 2010 to September 2020. 79 articles were identified, among them the researches involved medicinal plants, compounds isolated from medicinal plants and herbal medicines used in traditional Chinese medicine. In general, the research showed that the identified secondary metabolites showed anti-inflammatory and antioxidant activity that mostly belong to the class of flavonoids, alkaloids, saponins, coumarins and terpenes. |
| id |
UNIFEI_ec234799950bbab2d322fc8eb540ac5b |
|---|---|
| oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/17179 |
| network_acronym_str |
UNIFEI |
| network_name_str |
Research, Society and Development |
| repository_id_str |
|
| spelling |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020Plantas medicinales utilizadas em el tratamento de enfermidades respiratorias crónicas: De 2010 a 2020Plantas medicinais utilizadas no tratamento de doenças respiratórias crônicas: Período de 2010 a 2020Doença pulmonar obstrutiva crônicaPlantas medicinaisInflamação pulmonar.Chronic obstructive pulmonary diseaseMedicinal plantsPulmonar inflamation.Enfermedad pulmonar obstructiva crónicaPlantas medicinalesInflamación pulmonar.Chronic Obstructive Pulmonary Disease (COPD) is considered a set of respiratory diseases such as chronic bronchitis and pulmonary emphysema that are mainly characterized by progressive inflammation and reduced airflow in the airways. It developed mainly from active or passive smoking, inhalation of toxic gases or particles. Its treatment consists of reducing symptoms, progression and improving the lives of its patients. However, this treatment is limited and has side effects with prolonged use, which triggers the need to search for new therapies. The use of medicinal plants in the treatment of lung diseases is growing every day and is proving to be a viable and effective option. Its use is possible due to the presence of secondary metabolites, which have pharmacological activities such as anti-inflammatory and antioxidant. The objective of this work was to carry out a literature review of medicinal plants and active compounds used as a form of treatment for COPD from January 2010 to September 2020. 79 articles were identified, among them the researches involved medicinal plants, compounds isolated from medicinal plants and herbal medicines used in traditional Chinese medicine. In general, the research showed that the identified secondary metabolites showed anti-inflammatory and antioxidant activity that mostly belong to the class of flavonoids, alkaloids, saponins, coumarins and terpenes.La Enfermedad Pulmonar Obstructiva Crónica (EPOC) se considera un conjunto de enfermedades respiratorias como la bronquitis crónica y el enfisema pulmonar que se caracterizan principalmente por una inflamación progresiva y una reducción del flujo de aire en las vías respiratorias. Se desarrolló principalmente a partir del tabaquismo activo o pasivo, la inhalación de gases o partículas tóxicas. Su tratamiento consiste en reducir los síntomas, la progresión y mejorar la vida de sus pacientes. Sin embargo, este tratamiento es limitado y tiene efectos secundarios con un uso prolongado, lo que desencadena la necesidad de buscar nuevas terapias. El uso de plantas medicinales en el tratamiento de enfermedades pulmonares crece día a día y está demostrando ser una opción viable y eficaz. Su uso es posible debido a la presencia de metabolitos secundarios, que tienen actividades farmacológicas como antiinflamatorias y antioxidantes. El objetivo de este trabajo fue realizar una revisión de la literatura de plantas medicinales y compuestos activos utilizados como forma de tratamiento de la EPOC desde enero de 2010 a septiembre de 2020. Se identificaron 79 artículos, entre ellos las investigaciones involucradas en plantas medicinales, compuestos aislados de plantas medicinales. Plantas y medicinas a base de hierbas utilizadas en la medicina tradicional china. En general, la investigación mostró que los metabolitos secundarios identificados mostraron actividad antiinflamatoria y antioxidante que en su mayoría pertenecen a la clase de flavonoides, alcaloides, saponinas, cumarinas y terpenos.A Doença Pulmonar Obstrutiva Crônica (DPOC) é considerada um conjunto de doenças respiratórias como a bronquite crônica e enfisema pulmonar que são caracterizadas principalmente por inflamação progressiva e redução do fluxo de ar nas vias aéreas. Se desenvolvi sobretudo pelo tabagismo ativo ou passivo, inalação de gases ou partículas tóxicas. Seu tratamento consiste na redução de sintomas, progressão e melhorar a vida de seus portadores. Porém, este tratamento é limitado e apresenta efeitos colaterais com o uso prolongado, o que desencadeia a necessidade de busca de novas terapias. O uso de plantas medicinas, no tratamento de doenças pulmonares vem crescendo a cada dia e demostrando ser uma opção viável e eficaz. Seu uso é possível, devido a presença de metabolitos secundários, que apresentam atividades farmacológicas como anti-inflamatória e antioxidante. O objetivo deste trabalho foi realizar uma revisão bibliográfica das plantas medicinais e compostos ativos utilizados como forma de tratamento para DPOC no período de janeiro 2010 a setembro 2020. Identificou-se 79 artigos, dentre eles as pesquisas envolveram plantas medicinais, compostos isolados de plantas medicinais e fitoterápicos utilizados na medicina tradicional chinesa. Em geral, a pesquisa mostrou que os metabolitos secundários identificados apresentaram atividade anti-inflamatória e antioxidante que em sua maioria, pertencem a classe dos flavonoides, alcaloides, saponinas, cumarinas e terpenos.Research, Society and Development2021-07-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1717910.33448/rsd-v10i8.17179Research, Society and Development; Vol. 10 No. 8; e29710817179Research, Society and Development; Vol. 10 Núm. 8; e29710817179Research, Society and Development; v. 10 n. 8; e297108171792525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/17179/15511Copyright (c) 2021 Penina Sousa Mourão; Maria Lanna Souza da Silva; Rafael de Oliveira Gomes; Antônio Luiz Martins Maia Filho; Wellington dos Santos Alves; Valdiléia Teixeira Uchôahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMourão, Penina Sousa Silva, Maria Lanna Souza da Gomes, Rafael de Oliveira Maia Filho, Antônio Luiz Martins Alves, Wellington dos Santos Uchôa, Valdiléia Teixeira 2021-08-21T18:46:59Zoai:ojs.pkp.sfu.ca:article/17179Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:37:34.444933Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
| dc.title.none.fl_str_mv |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 Plantas medicinales utilizadas em el tratamento de enfermidades respiratorias crónicas: De 2010 a 2020 Plantas medicinais utilizadas no tratamento de doenças respiratórias crônicas: Período de 2010 a 2020 |
| title |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 |
| spellingShingle |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 Mourão, Penina Sousa Doença pulmonar obstrutiva crônica Plantas medicinais Inflamação pulmonar. Chronic obstructive pulmonary disease Medicinal plants Pulmonar inflamation. Enfermedad pulmonar obstructiva crónica Plantas medicinales Inflamación pulmonar. |
| title_short |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 |
| title_full |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 |
| title_fullStr |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 |
| title_full_unstemmed |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 |
| title_sort |
Medicinal plants used in the treatment of chronic respiratory diseases: From 2010 to 2020 |
| author |
Mourão, Penina Sousa |
| author_facet |
Mourão, Penina Sousa Silva, Maria Lanna Souza da Gomes, Rafael de Oliveira Maia Filho, Antônio Luiz Martins Alves, Wellington dos Santos Uchôa, Valdiléia Teixeira |
| author_role |
author |
| author2 |
Silva, Maria Lanna Souza da Gomes, Rafael de Oliveira Maia Filho, Antônio Luiz Martins Alves, Wellington dos Santos Uchôa, Valdiléia Teixeira |
| author2_role |
author author author author author |
| dc.contributor.author.fl_str_mv |
Mourão, Penina Sousa Silva, Maria Lanna Souza da Gomes, Rafael de Oliveira Maia Filho, Antônio Luiz Martins Alves, Wellington dos Santos Uchôa, Valdiléia Teixeira |
| dc.subject.por.fl_str_mv |
Doença pulmonar obstrutiva crônica Plantas medicinais Inflamação pulmonar. Chronic obstructive pulmonary disease Medicinal plants Pulmonar inflamation. Enfermedad pulmonar obstructiva crónica Plantas medicinales Inflamación pulmonar. |
| topic |
Doença pulmonar obstrutiva crônica Plantas medicinais Inflamação pulmonar. Chronic obstructive pulmonary disease Medicinal plants Pulmonar inflamation. Enfermedad pulmonar obstructiva crónica Plantas medicinales Inflamación pulmonar. |
| description |
Chronic Obstructive Pulmonary Disease (COPD) is considered a set of respiratory diseases such as chronic bronchitis and pulmonary emphysema that are mainly characterized by progressive inflammation and reduced airflow in the airways. It developed mainly from active or passive smoking, inhalation of toxic gases or particles. Its treatment consists of reducing symptoms, progression and improving the lives of its patients. However, this treatment is limited and has side effects with prolonged use, which triggers the need to search for new therapies. The use of medicinal plants in the treatment of lung diseases is growing every day and is proving to be a viable and effective option. Its use is possible due to the presence of secondary metabolites, which have pharmacological activities such as anti-inflammatory and antioxidant. The objective of this work was to carry out a literature review of medicinal plants and active compounds used as a form of treatment for COPD from January 2010 to September 2020. 79 articles were identified, among them the researches involved medicinal plants, compounds isolated from medicinal plants and herbal medicines used in traditional Chinese medicine. In general, the research showed that the identified secondary metabolites showed anti-inflammatory and antioxidant activity that mostly belong to the class of flavonoids, alkaloids, saponins, coumarins and terpenes. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-07-12 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/17179 10.33448/rsd-v10i8.17179 |
| url |
https://rsdjournal.org/index.php/rsd/article/view/17179 |
| identifier_str_mv |
10.33448/rsd-v10i8.17179 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/17179/15511 |
| dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Research, Society and Development |
| publisher.none.fl_str_mv |
Research, Society and Development |
| dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 8; e29710817179 Research, Society and Development; Vol. 10 Núm. 8; e29710817179 Research, Society and Development; v. 10 n. 8; e29710817179 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
| instname_str |
Universidade Federal de Itajubá (UNIFEI) |
| instacron_str |
UNIFEI |
| institution |
UNIFEI |
| reponame_str |
Research, Society and Development |
| collection |
Research, Society and Development |
| repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
| repository.mail.fl_str_mv |
rsd.articles@gmail.com |
| _version_ |
1797052681716498432 |